Company / Return on Assets (ROA)
Beam Therapeutics Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-5.4%
FY2025
5-year range
-34.1% / -5.4%
FY2021-FY2025
Trend
+84.2%
vs FY2024
Sector context
#75 of 213
Health Care
What the data says
At -5.4%, Beam Therapeutics Inc.'s return on assets (roa) ranks #75 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -50.2% in FY2019 to -5.4% in FY2025.
Based on SEC 10-K filings.
-5.4% in FY2025 with a 5-year CAGR of +11.9%.
Improved from -9.1% to -5.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +16.2pp
- 5-Year Change
- +11.9pp
- 10-Year Change
- -
Sector benchmark
#75 of 213 in Health CareTop 35% of 213This company -5.4% Sector average -24.1%
▼
+77.6% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 84.2% year-over-year.
- Currently 18.7pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5.4% | +84.2% |
| FY2024 | -34.1% | -275.9% |
| FY2023 | -9.1% | +57.9% |
| FY2022 | -21.6% | +14.3% |
| FY2021 | -25.1% | -45.0% |
| FY2020 | -17.3% | +65.4% |
| FY2019 | -50.2% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026